Hikma Pharmaceuticals PLC - ROE

The ROE as of June 2026 (TTM) for Hikma Pharmaceuticals PLC (HKMPY) is 15.83%

According to Hikma Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current ROE is 15.83%. This represents a change of 100.77% compared to the average of 7.88% of the last 4 quarters.

Hikma Pharmaceuticals PLC (HKMPY) Historical ROE (quarterly & annually)

How has HKMPY ROE performed in the past?

The mean historical ROE of Hikma Pharmaceuticals PLC over the last ten years is 7.66%. The current 15.83% ROE has changed 106.49% with respect to the historical average. Over the past ten years (40 quarters), HKMPY's ROE was at its highest in in the June 2014 quarter at 14.71%. The ROE was at its lowest in in the December 2017 quarter at -60.24%.

Hikma Pharmaceuticals PLC (HKMPY) ROE by Quarter and Year

Discovering the peaks and valleys of Hikma Pharmaceuticals PLC ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hikma Pharmaceuticals PLC (HKMPY) Average ROE

How has HKMPY ROE performed in the past?

The current ROE of Hikma Pharmaceuticals PLC (HKMPY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hikma Pharmaceuticals PLC (HKMPY) ROE vs. Peers

How is HKMPY’s ROE compared to its peers?

Hikma Pharmaceuticals PLC’s ROE is less than H. Lundbeck A/S (14.81%), less than H. Lundbeck A/S (14.81%), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (7.70%), less than Siegfried Holding AG (15.68%), less than Livzon Pharmaceutical Group Inc. (13.95%), less than Ono Pharmaceutical Co., Ltd. (8.54%), less than Sumitomo Pharma Co., Ltd. (41.78%), less than Sumitomo Pharma Co., Ltd. (41.78%), less than Ono Pharmaceutical Co., Ltd. (8.54%), less than Zealand Pharma A/S (42.59%),

Build a custom stock screener for Hikma Pharmaceuticals PLC (HKMPY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hikma Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hikma Pharmaceuticals PLC (HKMPY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hikma Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.